Navigation Links
BioElectronics Corp Aggressively Expands Sales into Middle East

New Sales Agent and Distributor Has Extensive Pharmaceutical Experience

throughout the Region

FREDERICK, Md., Sept. 10 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announced today that it has appointed Abdulkader Al-Mehyar Moh'd Basheer Halawy as sales agent and distributor in the Middle Eastern region. The company launched the new sales program with orders for 20,000 units.

"These are significant initial orders for BioElectronics Corporation showing that this region has a strong demand for drug-free medical products," said Andrew J. Whelan, CEO of BioElectronics Corporation. "There is well established need for drug free anti inflammatory therapy in the Middle East which we expect to capture and expand."

Whelan explained that Dr. Halawy has had significant sales management and training experience at Pfizer and several other leading pharmaceutical companies. As demonstrated by his initial launch, Dr. Halawy has developed an extensive network of contacts throughout the region. He will be located in Riyadh, and will be responsible for sales throughout the region.

BioElectronics Corporation (OTC Pink Sheets: BIEL) is the maker of inexpensive, drug-free, anti-inflammatory medical devices and patches. The Company's inexpensive wafer thin patches and devices contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch(TM) and RecoveryRx(TM). The dermal patch delivery system creates a multitude of new product opportunities for chronic and acute inflammatory conditions.

For more information visit or call 866-757-2284.

Information on ActiPatch and BioElectronics Corporation is available at the following websites:

-- U.S. Consumer

-- Podiatry:

-- Plastic Surgery: and

-- German orthopedic foot & ankle:

-- Italy and Switzerland:

-- Canada:

-- Netherlands:

-- Singapore & Malaysia:

-- Denmark:

-- BioElectronics Corp:

Safe Harbor Statement

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.


Kelly Lorenz

BioElectronics Corporation

4539 Metropolitan Court

Frederick, MD 21704

866-757-2284 ext 101

301-874-4890 ext 101

301-874-6935 fax

SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corporation Announces Singapore and Malaysia Sales
2. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
3. BioElectronics Announces Canadian Retail Product Launch
4. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
5. BioElectronics Corporation Receives Major Orders From Italian Distributor
6. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
7. BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
8. BioElectronics Announces Distribution Agreement for Sales In India
9. ATS Medical Expands Open Pivot Heart Valve Offerings
10. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
11. BioLife Solutions Expands Scientific Advisory Board
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... --> --> ... Synthesis Market by Product & Services (Primer, Probe, Custom ... RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - ... is expected to reach USD 1,918.6 Million by 2020 ... of 10.1% during the forecast period. Browse ...
Breaking Biology Technology:
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
Breaking Biology News(10 mins):